INS and type 1 diabetes mellitus: Although it remains controversial whether SGLT2i can be combined with insulin to treat type 1 diabetes mellitus (T1DM) because of safety issues, recent meta-analyses of clinical trials have demonstrated a reduction in HbA1c levels of approximately 0.4% in patients with T1DM [29, 30].